Research into the pathogenesis of hypertension has, in tors are known to be involved in thrombogenesis, their potential role in the pathogenesis of patients with hyperthe past, tended to concentrate on changes in vascular geometry, cardiac output and blood volume. However, tension has received increasing attention. The purposes of this review are to update previous reviews and to patients with hypertension are known to be at an increased risk of both coronary heart disease and ceresummarise the relationship between hypertension, its complications and treatment and a range of haemorheobrovascular disease; complications which are thrombotic in origin. Since rheological and haemostatic faclogical factors.
Introduction sity, the dependence of blood viscosity on flow Hypertension is recognised as a major risk factor for conditions suggests that abnormalities in haemothe development of myocardial infarction and rheological factors may be involved in the complistroke. 1, 2 Whereas advances in pharmacology have cations of hypertension, as well as in the determiled to increasingly effective antihypertensive drug nation of BP itself. 4 The complications of therapy, the pathological mechanisms of hypertenhypertension, such as myocardial infarction and sion are still poorly understood. Systemic arterial stroke have a thrombotic basis. The factors generally blood pressure (BP) depends on both cardiac output accepted to be important in thrombus formation are and on total peripheral resistance. In turn, periphknown as Virchow's triad: 5 abnormalities of the veseral resistance is affected by the diameter of the sel wall; the composition of the blood (platelets and arterioles and capillaries and also by blood viscosity the coagulation and fibrinolytic systems) and the ( Figure 1) .
flow of blood in the vessel. The purposes of this One of the most important functional rheological review are to update previous reviews 4, 6, 7 and to properties of blood is its resistance to flow or vissummarise the relationships between hypertension, cosity. 3 The flow streamlines of blood are disturbed its complications and treatment, and a range of rheoby large plasma proteins and also by the erythrological and haemostatic factors, which are increascytes in the plasma. At high shear rates, blood visingly recognised as determinants of cardiovascular cosity is low. However, since conditions of low events. 8 shear rates arise at sites of atherogenesis, thromboIn recent years, it has become evident that rheological and haemostatic factors are both primary and secondary predictors of cardiovascular events. Mounting evidence of their prognostic value raises the possibility that they are not merely markers or consequences of atherothrombotic disease, but may also contribute to its pathogenesis. Since the primary factors governing blood viscosity are the haematocrit, plasma viscosity and red cell deformability and aggregation, evidence relating each of these to hypertension will be reviewed in turn. This is followed by brief summaries of those studies which have examined (a) the roles of haemostatic factors in hypertension and (b) the effects of antihypertensive therapy on rheological and haemostatic factors. suggested that hypertension activates coagulation which leads to intrarenal fibrin deposition and renal failure. It is also possible that renal damage might then activate haemostasis, promoting further renal hypertensives compared with a control group, [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] although most have been based on a relatively small damage and setting up a vicious circle. Table 2 shows that significant correlations number of subjects. In contrast, one recent paper by Vayá et al 18 noted no difference in haematocrit level between BP and haematocrit have been reported in a range of population studies, [26] [27] [28] [29] [30] [31] [32] [33] although this does when comparing a group of 21 hypertensives with a group of controls, which agreed with some earlier not seem to be true among hypertensive patients, 34 possibly due to the effects of treatment and/or renal reports.
11, 20 An increased haematocrit among hypertensives could be due to either an increase in red impairment. Most of the epidemiological studies have reported a stronger relationship of haematocrit blood cell mass or to a contracted plasma volume. One study indicated that, compared to a control with diastolic BP (DBP) than with systolic BP (SBP). [27] [28] [29] [30] 32 This is consistent with the contribution group of 24 subjects, 45 patients with mild hypertension had similar haematocrit, red blood cell mass of the haematocrit, and hence blood viscosity, to peripheral vascular resistance, which is a determiand plasma volume levels. In contrast, 43 other subjects with moderate to severe hypertension had a nant of DBP. 12 There is no agreement as to whether the relationship between BP and haematocrit is significantly increased haematocrit, which was attributed solely to a decreased plasma volume, since stronger for men than for women. red blood cell mass was normal.
14 In another study, 9 compared with normotensives, hypertensives
Plasma viscosity
showed a decreased plasma volume during exercise with resulting increases in haematocrit, plasma pro- Table 3 shows that increases in plasma viscosity among hypertensives have been confirmed in varitein and blood viscosity.
There are a range of disorders which are characterous case-control studies. thesis of fibrinogen and other acute-phase pro-
teins. 37, 38 Epidemiological studies [26] [27] [28] [29] [30] [31] [32] [33] have tended to con- during follow-up in those few subjects (25 men and 24 women) who did so. reported that haematocrit-matched hypertensives showed an increased plasma viscosity which largely accounted for the 5-10% increase in blood viscosity
Red cell rigidity (lack of deformability)
at high shear rates. The MONICA Augsburg study 36 showed a strong independent association of plasma Blood flow through the vascular system is dependent on the ability of the red blood cells to adapt viscosity with hypertension in men only, after stratification for confounding factors. Increased plasma the most suitable configuration for passage through the capillaries and, when the diameter of the vessel viscosity in arterial hypertension may result from a reduction in intravascular fluid volume by a transcais very small, it is necessary for the red cell to deform during passage through. The deformability pillary shift of fluid into the interstitial space. An elevated capillary hydrostatic filtration pressure of the red blood cells depends mainly on the fluidity of the cell membrane, the viscosity of the cytoplasm significantly increased red blood cell aggregation and disaggregation shear rate and shear stress were and the cell membrane surface area to cell volume ratio. Early studies which measured red cell deformobserved in hypertensive subjects. From the epidemiological perspective, a French population study 28 ability tended to give conflicting results because of white blood cell and plasma protein contamination. reported that red blood cell aggregation was a more important determinant of whole blood viscosity at In some studies, the increased blood viscosity among hypertensives has not been entirely most shear rates than was plasma viscosity. Results from the second Scottish MONICA Survey 29 showed explained by increases in haematocrit or plasma viscosity. 27, 32, 39 An early study of 71 hypertensives 39 that men had significantly lower red cell aggregation levels than women, which could partly be explained noted a stronger relationship between red cell rigidity and SBP than with diastolic pressure. In by their higher haematocrit and lower fibrinogen levels. In addition, red cell aggregation correlated addition, the effect was more pronounced in men than in women. A role for red cell rigidity in the positively with both systolic and diastolic BP in men (r = 0.12 and r = 0.16, respectively), although aetiology of hypertension was thus suggested, although the mechanism of action is still unclear.
the correlations in women were weaker (r = 0.07 and r = 0.03, respectively). However, neither BP showed Reduced filterability of red cells in hypertensives has been reported. 6, 18 Another study used red cell an independent association with red cell aggregation after adjusting for other cardiovascular risk factors fluidity as a measure of erythrocyte deformability, and noted lower levels among subjects with hypersuch as age, smoking, body mass index and lipids. Such studies suggest that enhanced red cell aggretension. 17 It was suggested that this reduced fluidity may be explained by an enlarged metabolic pool of gation under low shear conditions can lead to an increased blood viscosity. Furthermore, the obserfree calcium ions in the red blood cells of patients with essential hypertension. 40 This seems plausible vation that the disaggregation shear rate threshold is raised in hypertensives 42 can be interpreted as a since earlier work had noted a reduction in the number of calcium binding sites on the inner surface of stronger adhesive force between the red blood cells within rouleaux. Such parameters may be relevant the erythrocyte membrane in hypertensives. 41 However, the fluidity of the cell membrane, on which the to an increased risk of vascular complications which are associated with low flow conditions including deformability of the erythrocyte depends, may be influenced by other factors such as the lipids which atherogenesis, thrombogenesis and ischaemia. 3 form part of the membrane bilayer.
In the Scottish Heart Health Study, 30 it was shown
Blood rheology and the left ventricle in
that, after adjustment for plasma viscosity, haematohypertension crit and fibrinogen, the residual variation in whole blood viscosity (relative blood viscosity, which, Hypertension results in increased pressure afterload when measured at high shear rates, is due to erythroon the left ventricle producing compensatory left cyte rigidity or lack of deformability) showed no sigventricular hypertrophy. The presence of left vennificant correlation with BP. In contrast, the Edintricular hypertrophy among subjects with hypertenburgh Artery Study of older subjects did find a sion may be important since it may contribute to relationship between relative blood viscosity and their increased risk of sudden death, coronary heart both systolic and diastolic BP, predominantly in disease, arrhythmias, heart failure and stroke. Howmen. 32 The general message seems to be that ever, whether the abnormalities in blood rheology impaired red cell deformability may possibly also are a determinant of, or a response to, hypertensive contribute to hyperviscosity in hypertension. left ventricular hypertrophy is unclear. It has been suggested that blood viscosity may be important in the pathogenesis of left ventricular hypertrophy
Red cell aggregation
because of significant correlations with left ventricuThe aggregation of red blood cells is a reversible lar mass. 13, 43 Furthermore, hypertensive cardiac phenomenon that occurs with macromolecules hypertrophy was reported to be more closely related bridging the membranes of adjacent cells, and is to rheological abnormalities than to the level of BP. influenced by the shearing forces exerted on blood, It has also been suggested that vasoconstriction may the properties of erythrocytes (including conceninduce both haemoconcentration (resulting in tration, deformability and shape) and the concenincreased blood viscosity), and increased peripheral trations, lengths and bridging force of high molecuresistance as a stimulus to myocardial hypertrophy. lar weight plasma proteins, especially fibrinogen.
In contrast, both stroke volume and plasma volume This phenomenon represents an equilibrium have been positively related to left ventricular mass between the macromolecules bridging force, the in hypertensives. 44 Since it is still unclear whether electrical charges on the surface of the red blood blood rheology is a cause or effect of hypertensive cells and the shear stress. When the macromolecules cardiac hypertrophy, further studies are warranted. bridging force is increased in pathological conditions, the shear stress needed to break up red Fibrinogen blood cell aggregates is increased.
One early case-control study 20 noted that subjects Next to haematocrit, fibrinogen is the most important determinant of blood viscosity, due to its with hypertension had significantly higher levels of red cell aggregation when compared to the controls strong effects on both plasma viscosity and red cell aggregation. Fibrinogen is also important in haemo-(19.8 ± 0.8 vs 14.0 ± 0.6, P Ͻ 0.01). In a later study, 42 stasis and thrombosis. 8 The formation of plateletthat fibrinogen does not have a strong independent role in determining BP in the general population. rich mural thrombi is enhanced through bridging of platelets into aggregates by fibrinogen; it is also the Table 5 shows that most of the studies on subjects with hypertension have shown an elevated fibrinoprecursor of fibrin.
The association between hypertension and hypergen level compared with normotensive controls, 12,16,18,59-62 although two have noted no differfibrinogenaemia has long been known. Letcher et al 12 reported that in haematocrit-matched hypertenence in fibrinogen level between these two groups. 62 , 63 Fogari et al 64 reported that, among male sives, the levels of fibrinogen and other globulins are increased and suggested that this may partly hypertensives, there was only a weak correlation between fibrinogen and BP (systolic r ϭ 0.14 and account for their higher blood viscosity. The increase in fibrinogen was too great to arise wholly diastolic r = 0.06) and similarly with family history of hypertension (r = 0.18). When these subjects were from a contracted volume, and may be due to a chronic phase protein reaction, possibly associated further divided into those with and without a family history of hypertension, cigarette smoking and lipid with increased catecholamine secretion which is a feature of hypertension.
abnormalities showed the strongest correlations with fibrinogen in the family history group. Thus, Early epidemiological data relating fibrinogen to BP indicated a significant, positive univariate the presence of a family history of hypertension among hypertensives would appear to enhance the effect, [45] [46] [47] [48] [49] 32 or reversed the posialso an important cofactor for platelet adhesion and aggregation, especially at high shear rates. or chronic low-grade intravascular coagulation. 24 reported that vWF levels were significantly higher in patients with hypertension who did not have conRegression models attempting to assess the independent influence of BP on fibrinogen levels have current vascular disease or risk factors (131 ± 34 IU/dl) compared with controls (90 ± 30 IU/dl). Howshown varying results. In two, 52 ,55 SBP had a weak, but independent effect in women only. A study of hypertensive diabetic Nigerians found that fibrino- Blood pressure values are mm Hg. whose hypertension had been controlled by drug therapy (104 ± 29 IU/dl). In subjects with uncontrolled or controlled hypertension, who additionally had vascular disease or elevated risk factors, levels taken into account. A strong positive association of vWF were also raised. A significant correlation among hypertensives between PAI-1 and the level was noted between absolute levels of vWF and both of both insulin and lipoprotein and a negative systolic and diastolic BP among patients with either relationship with the rate of glucose disposal have controlled or uncontrolled hypertension in the been shown. 59, 62, 73 In a study of non-obese hypertenabsence of vascular disease or risk factors. This, sive men, treatment with metformin lowered BP and coupled with the finding that concurrent vascular tended to increase the fibrinolytic activity of the disease or risk factors were not associated with any subjects. 75 Similarly, DBP was independently and significant further rise in vWF over that seen with inversely associated with tPA activity among hyperuncontrolled hypertension alone, may suggest a tensives. 73 Epidemiological studies 55, 67, 76, 77 have 'plateau' effect above which there is no additional tended to support the clinical findings with strong release of vWF from the endothelial cells. In contrast correlations between BP and both PAI-1 and t-PA to these findings, two case-control studies reported reported (Table 8) . Such studies appear to indicate no significant difference in vWF levels between that both BP and concomitant metabolic disturbhypertensive patients and normotensives. 62, 66 Very ances may mediate the reduced fibrinolytic capacity few population studies have examined the associ-(high PAI-1 and tPA antigen levels) observed ation between vWF and BP in any detail, although among hypertensives. in the two that have, neither found an independent effect. 67, 68 While endothelial disturbance may play a role in hypertension, further studies of its relationship to plasma vWF levels are required. cardiovascular death. [69] [70] [71] [72] Table 7 shows that PAI-1 explained by the higher PAI-1 levels). 73 However, the fibrinolytic system, such confounders need to be alterations in rheology in one study, 84 while others
Other haemostatic factors
have reported a beneficial effect on platelet actiOne study reported no significant difference in vation and aggregation in hypertensives. 87 More plasma beta-thromboglobulin (a marker of platelet recently, Wysocki et al 88 reported that, in a group activation) between hypertensives and normotenof hypertensive men, a single dose of cadralazine (a sives, 66 whilst a significant elevation in malignant hydralazine-related vasodilator) caused vasodilahypertensives has been shown, possibly due to tation (a decrease in the total peripheral resistance reduced renal clearance. 24 Fibrin D-dimer is a crossindex) and was accompanied by haemodilution (a linked fibrin degradation product and plasma levels reduction in haematocrit and blood viscosity). A of D-dimer give an index of the turnover of crossdose-dependent improvement in the red cell rigidity linked fibrin. Although not a blood coagulation facindex after treatment with urapidil has been tor per se, correlations within the population range reported 89 , whereas compounds such as diuretics 87 of BP, together with elevated levels among hypertenand omega-3 fatty acids 90 appear to have no effect sives, have been noted 24, 63, 67, 78, 79 and the epidemioon platelet function and plasma fibrinogen level. logical studies are summarised in Table 9 . Factor However, most of the studies referred to above VII, an important cofactor in the initiation of blood have been short-term clinical trials, often crossover coagulation by the tissue factor pathway showed in design, and all were based on a relatively small weak associations with BP in one epidemiological number of hypertensive patients. No information study, 67 but, together with Factor VIII, has been about the long-term effects of therapy on prognosis shown to be significantly raised in hypertensives. 63 is available and hence there is a need for large scale These individual studies suggest that factors intervention studies which look in particular at the involved in blood coagulation, other than fibrinogen effects of treatment on a wide range of haemostatic and vWF, may have a role in the aetiology of hyperand rheological factors. tension, although more research is obviously warranted.
Significance of haemorheology in hypertension Therapeutic intervention
As we have seen, essential hypertension is characBecause blood viscosity appears to be a determinant terised by an increase in blood viscosity. Although of both increased BP, and its complications this can be explained in some studies by an elevated (thrombotic events and left ventricular haematocrit, plasma viscosity or fibrinogen level, hypertrophy), the effects of antihypertensive therother mechanisms such as a reduced red cell apy are of interest. Until recently, it appeared that deformability have been proposed. The mechanisms vasodilators improved blood rheology, ␤-adrenergic for the haemorheological abnormalities in patients blockers had no effect and diuretics had an adverse with hypertension are not clear. Elevated blood viseffect. 4, 6 Table 10 summarises the recent studies cosity tends to increase BP and to decrease organ which have examined the effects of antihypertensive blood flow (which, in the absence of compensatory drugs on blood coagulation and rheology. Antihychanges, hinders oxygen delivery, creating an pertensive treatment with calcium-channel blockers ischaemic state); it also increases platelet adhesion has shown limited success in improving the flow to the sub-endothelium, thereby possibly facilitating properties of the blood in some studies 80, 81 whilst thrombus formation in stenosed arteries. others have found little or no change in blood or
The major complications of essential hypertenplasma viscosity during chronic vasodilatation with sion are ischaemic heart disease and stroke and sevsuch medication. [82] [83] [84] Treatment with beta-blockers eral epidemiological studies [48] [49] [50] have related haeappears to exert beneficial effects on blood vismostatic factors and, more recently, rheological cosity 81,85,86 and reductions in measures of platelet factors 91-94 to the incidence of both. A report from activation. 83 ACE inhibitors have shown negligible the Caerphilly and Speedwell studies 91 showed that fibrinogen, plasma viscosity, white cell count and smoking predicted ischaemic heart disease just as Ͼ3.5g/l had a 12-fold increased risk of cardiovascu-
